Does ivermectin have a place in the treatment of mild Covid-19?

New Microbes New Infect · 2022 · PMC9135450 · PMID 35664917

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

At the beginning of the COVID pandemic, ivermectin was tested in vitro against SARS-CoV-2 and showed a highly significant reduction (99.8%) in viral RNA after 48 hours [ 1 ], but it was criticized that this was achieved by using a much higher dose in comparison to the standard dose in human use [ 2 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.